LLY
Price
$533.83
Change
-$3.14 (-0.58%)
Updated
Oct 2, 9:09 AM EST
31 days until earnings call
MRK
Price
$101.83
Change
-$1.17 (-1.14%)
Updated
Oct 2, 1:29 PM EST
24 days until earnings call

Analysis and predictions LLY vs MRK

Header iconLLY vs MRK Comparison
Open Charts LLY vs MRKBanner chart's image
Eli Lilly & Co
Price$533.83
Change-$3.14 (-0.58%)
Volume$1.1K
CapitalizationN/A
Merck & Co
Price$101.83
Change-$1.17 (-1.14%)
Volume$2.51K
CapitalizationN/A
View a ticker or compare two or three
LLY vs MRK Comparison Chart

Loading...

Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
VS
LLY vs. MRK commentary
Oct 02, 2023

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is LLY is a StrongSell and MRK is a StrongSell.

COMPARISON
Comparison
Oct 02, 2023
Stock price -- (LLY: $537.13 vs. MRK: $102.95)
Brand notoriety: LLY and MRK are both notable
Both companies represent the Pharmaceuticals: Major industry
Current volume relative to the 65-day Moving Average: LLY: 100% vs. MRK: 104%
Market capitalization -- LLY: $516.84B vs. MRK: $264.66B
LLY [@Pharmaceuticals: Major] is valued at $516.84B. MRK’s [@Pharmaceuticals: Major] market capitalization is $264.66B. The market cap for tickers in the [@Pharmaceuticals: Major] industry ranges from $516.84B to $0. The average market capitalization across the [@Pharmaceuticals: Major] industry is $79.84B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

LLY’s FA Score shows that 3 FA rating(s) are green whileMRK’s FA Score has 3 green FA rating(s).

  • LLY’s FA Score: 3 green, 2 red.
  • MRK’s FA Score: 3 green, 2 red.
According to our system of comparison, LLY is a better buy in the long-term than MRK.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

LLY’s TA Score shows that 3 TA indicator(s) are bullish while MRK’s TA Score has 4 bullish TA indicator(s).

  • LLY’s TA Score: 3 bullish, 5 bearish.
  • MRK’s TA Score: 4 bullish, 7 bearish.
According to our system of comparison, MRK is a better buy in the short-term than LLY.

Price Growth

LLY (@Pharmaceuticals: Major) experienced а -2.44% price change this week, while MRK (@Pharmaceuticals: Major) price change was -3.19% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Major industry was -1.21%. For the same industry, the average monthly price growth was -4.49%, and the average quarterly price growth was -4.22%.

Reported Earning Dates

LLY is expected to report earnings on Nov 02, 2023.

MRK is expected to report earnings on Oct 26, 2023.

Industries' Descriptions

@Pharmaceuticals: Major (-1.21% weekly)

The Major Pharmaceuticals industry includes companies that are involved in various processes of creating drugs to treat/prevent diseases. These companies engage in research, testing and manufacturing, as well as the distribution of pharmaceuticals into markets. Johnson & Johnson, Merck & Co., Inc., Pfizer Inc. and Novartis are among the largest companies in this category.

SUMMARIES
A.I.dvisor published
a Summary for LLY with price predictions.
OPEN
A.I.dvisor published
a Summary for MRK with price predictions.
OPEN
FUNDAMENTALS
Fundamentals
LLY($517B) has a higher market cap than MRK($265B). MRK has higher P/E ratio than LLY: MRK (85.47) vs LLY (75.76). LLY YTD gains are higher at: 47.996 vs. MRK (-5.300). MRK has higher annual earnings (EBITDA): 10.2B vs. LLY (9.14B). MRK has more cash in the bank: 6.38B vs. LLY (2.83B). LLY has less debt than MRK: LLY (18.8B) vs MRK (36.9B). MRK has higher revenues than LLY: MRK (58.3B) vs LLY (29.5B).
LLYMRKLLY / MRK
Capitalization517B265B195%
EBITDA9.14B10.2B90%
Gain YTD47.996-5.300-906%
P/E Ratio75.7685.4789%
Revenue29.5B58.3B51%
Total Cash2.83B6.38B44%
Total Debt18.8B36.9B51%
FUNDAMENTALS RATINGS
LLY vs MRK: Fundamental Ratings
LLY
MRK
OUTLOOK RATING
1..100
7858
VALUATION
overvalued / fair valued / undervalued
1..100
64
Fair valued
15
Undervalued
PROFIT vs RISK RATING
1..100
16
SMR RATING
1..100
1777
PRICE GROWTH RATING
1..100
3754
P/E GROWTH RATING
1..100
263
SEASONALITY SCORE
1..100
n/a50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

MRK's Valuation (15) in the Pharmaceuticals Major industry is somewhat better than the same rating for LLY (64). This means that MRK’s stock grew somewhat faster than LLY’s over the last 12 months.

LLY's Profit vs Risk Rating (1) in the Pharmaceuticals Major industry is in the same range as MRK (6). This means that LLY’s stock grew similarly to MRK’s over the last 12 months.

LLY's SMR Rating (17) in the Pharmaceuticals Major industry is somewhat better than the same rating for MRK (77). This means that LLY’s stock grew somewhat faster than MRK’s over the last 12 months.

LLY's Price Growth Rating (37) in the Pharmaceuticals Major industry is in the same range as MRK (54). This means that LLY’s stock grew similarly to MRK’s over the last 12 months.

MRK's P/E Growth Rating (3) in the Pharmaceuticals Major industry is in the same range as LLY (26). This means that MRK’s stock grew similarly to LLY’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
LLYMRK
RSI
ODDS (%)
Bearish Trend 4 days ago
56%
Bullish Trend 4 days ago
69%
Stochastic
ODDS (%)
Bullish Trend 4 days ago
68%
Bullish Trend 4 days ago
57%
Momentum
ODDS (%)
Bearish Trend 4 days ago
55%
Bearish Trend 4 days ago
59%
MACD
ODDS (%)
Bearish Trend 4 days ago
45%
Bearish Trend 4 days ago
39%
TrendWeek
ODDS (%)
Bearish Trend 4 days ago
50%
Bearish Trend 4 days ago
47%
TrendMonth
ODDS (%)
Bearish Trend 4 days ago
50%
Bearish Trend 4 days ago
38%
Advances
ODDS (%)
Bullish Trend 8 days ago
67%
Bullish Trend 25 days ago
52%
Declines
ODDS (%)
Bearish Trend 4 days ago
52%
Bearish Trend 6 days ago
44%
BollingerBands
ODDS (%)
Bearish Trend 4 days ago
40%
Bullish Trend 4 days ago
60%
Aroon
ODDS (%)
Bullish Trend 4 days ago
72%
Bearish Trend 4 days ago
46%
View a ticker or compare two or three
Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
MORF22.880.39
+1.73%
Morphic Holding
WDAY214.853.63
+1.72%
Workday
FSI2.720.04
+1.49%
Flexible Solutions International
IPAR134.26-1.23
-0.91%
Inter Parfums
PRTH3.24-0.04
-1.22%
Priority Technology Holdings

LLY and

Correlation & Price change

A.I.dvisor indicates that over the last year, LLY has been loosely correlated with BIIB. These tickers have moved in lockstep 50% of the time. This A.I.-generated data suggests there is some statistical probability that if LLY jumps, then BIIB could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To LLY
1D Price
Change %
LLY100%
-1.34%
BIIB - LLY
50%
Loosely correlated
-0.30%
NVS - LLY
42%
Loosely correlated
-0.46%
MRK - LLY
42%
Loosely correlated
-1.29%
AMGN - LLY
40%
Loosely correlated
-0.76%
GILD - LLY
39%
Loosely correlated
-0.62%
More